Natural selection of FLT1 alleles and their association with malaria resistance in utero.
Placental malaria (PM) caused by Plasmodium falciparum contributes significantly to infant mortality in sub-Saharan Africa and is associated with pregnancy loss. We hypothesized that fetal genes that modify PM would be associated with fetal fitness. During PM, placental trophoblasts produce soluble fms-like tyrosine kinase 1 (sFlt1), also known as soluble VEGF receptor 1, an angiogenesis inhibitor associated with preeclampsia. Here we present a study examining the genotype of the fms-related tyrosine kinase 1 (FLT1) 3' UTR in Tanzanian mother-infant pairs. First-time mothers suffer the most PM, and newborn FLT1 genotype distribution differed by birth order, with newborns of first-time mothers outside of Hardy-Weinberg equilibrium (HWE) during peak PM season. Among first-time but not other mothers, maternal FLT1 genotype was associated with a history of prior pregnancy loss. During PM, newborn FLT1 genotype was associated with low birth weight and placental inflammatory gene expression. FLT1 genotype was also associated with Flt1 levels among study subjects and in vitro. Thus, FLT1 variants confer fetal fitness in utero and are associated with the maternal immune response during PM. This indicates that FLT1 is under natural selection in a malaria endemic area and that human exposure to malaria can influence the evolutionary genetics of the maternal-fetal relationship.
Muehlenbachs
Atis
A
Mother-Offspring Malaria Studies Project, Seattle Biomedical Research Institute, Seattle, WA 98109, USA.
Fried
Michal
M
Lachowitzer
Jeff
J
Mutabingwa
Theonest K
TK
Duffy
Patrick E
PE
D000022:Abortion, Spontaneous / Q000453:epidemiology / Q000235:genetics; D000483:Alleles; D001722:Birth Order; D018900:Dinucleotide Repeats / Q000235:genetics; D005260:Female; D005786:Gene Expression Regulation; D005838:Genotype; D006801:Humans; D007113:Immunity, Innate / Q000235:genetics*; D007231:Infant, Newborn; D007249:Inflammation / Q000453:epidemiology / Q000235:genetics; D008288:Malaria / Q000453:epidemiology / Q000235:genetics*; D010298:Parity; D010922:Placenta Diseases / Q000453:epidemiology / Q000235:genetics; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000453:epidemiology / Q000235:genetics*; D012621:Seasons; D012641:Selection, Genetic; D013636:Tanzania / Q000453:epidemiology; D020506:Untranslated Regions / Q000235:genetics; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000235:genetics*
D020506:Untranslated Regions; C501162:FLT1 protein, human; D040281:Vascular Endothelial Growth Factor Receptor-1
Am J Obstet Gynecol. 2005 Jul;193(1):16-22
16021053
J Exp Med. 2006 Jun 12;203(6):1447-58
16702604
Nature. 1998 Oct 29;395(6705):851-2
9804416
Eur J Immunogenet. 1999 Oct;26(5):321-3
10553496
Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):35-40
15331817
PLoS Med. 2006 Nov;3(11):e446
17105340
Lab Invest. 2000 Aug;80(8):1195-205
10950110
Biol Reprod. 1998 Dec;59(6):1540-8
9828203
Immunol Today. 1993 Jul;14(7):353-6
8363725
J Immunol. 2007 Jul 1;179(1):557-65
17579077
PLoS Med. 2005 Dec;2(12):e407
16259531
N Engl J Med. 2004 Feb 12;350(7):672-83
14764923
Curr Top Dev Biol. 2005;71:297-312
16344109
Science. 1996 Jun 7;272(5267):1502-4
8633247
Nature. 2005 Oct 27;437(7063):1299-320
16255080
Endocrinology. 2004 Nov;145(11):4838-45
15284201
Nucleic Acids Res. 1991 May 25;19(10):2803
2041764
J Clin Invest. 2003 Mar;111(5):649-58
12618519
Cochrane Database Syst Rev. 2006 Oct 18;(4):CD000169
17054128